Hims & Hers Health (HIMS) awards 260 RSUs to Chief Medical Officer

Q: What equity award did HIMS Chief Medical Officer Patrick Carroll receive?

Patrick Carroll received 260 Restricted Stock Units (RSUs) , each representing one share of Class A Common Stock. The award was granted as part of director compensation and will vest in full on the company’s next quarterly vesting date.

Q: How was the number of RSUs for HIMS insider Patrick Carroll determined?

The 260 RSUs were calculated by dividing foregone director cash fees of $7,912 by a grant price of $30.40 per share. This converts the quarterly retainer into equity under the Director Compensation Policy.

Q: What is the vesting schedule for Patrick Carroll’s RSUs at HIMS?

The RSUs granted to Patrick Carroll will vest in full on the company’s next quarterly vesting date . After vesting, each RSU entitles him to receive one share of Class A Common Stock, subject to applicable plan terms.

Q: Did Patrick Carroll buy or sell any HIMS shares in this Form 4?

No open-market buy or sell occurred; the filing reports an award of 260 RSUs as compensation. The transaction is coded as a grant/award acquisition, increasing his reported derivative-based equity position.

Q: What is Patrick Carroll’s HIMS holding reported after this RSU grant?

Following the reported transaction, Patrick Carroll holds 260 Restricted Stock Units related to Class A Common Stock. These RSUs are contingent rights that convert into shares upon vesting according to the company’s equity plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Carroll Patrick Harrison reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. reported that Chief Medical Officer Patrick Harrison Carroll received a grant of 260 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The award was issued under the company’s Director Compensation Policy in lieu of a second-quarter 2026 director retainer fee of $7,912, based on a grant price of $30.40 per share. The RSUs will vest in full on the company’s next quarterly vesting date, after which the underlying shares may be delivered.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Carroll Patrick Harrison

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit ^{F1, F2}	260	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 260 shares (Direct)

Footnotes (2)

F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $7,912 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Key Figures

RSUs granted: 260 RSUs Foregone cash fees: $7,912 Grant price: $30.40 per share +1 more

4 metrics

RSUs granted 260 RSUs Restricted Stock Units representing Class A Common Stock granted to Patrick Carroll

Foregone cash fees $7,912 Director retainer fee for Q2 2026 converted into RSUs

Grant price $30.40 per share Amount used to convert foregone cash fees into RSUs

RSUs after transaction 260 Total Restricted Stock Units held following the reported award

Key Terms

Restricted Stock Units, Director Compensation Policy, vesting date

3 terms

Restricted Stock Units financial

"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Director Compensation Policy financial

"issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu"

vesting date financial

"The RSUs will vest in full on the Company's next quarterly vesting date."

FAQ

What equity award did HIMS Chief Medical Officer Patrick Carroll receive?

Patrick Carroll received 260 Restricted Stock Units (RSUs), each representing one share of Class A Common Stock. The award was granted as part of director compensation and will vest in full on the company’s next quarterly vesting date.

How was the number of RSUs for HIMS insider Patrick Carroll determined?

The 260 RSUs were calculated by dividing foregone director cash fees of $7,912 by a grant price of $30.40 per share. This converts the quarterly retainer into equity under the Director Compensation Policy.

What is the vesting schedule for Patrick Carroll’s RSUs at HIMS?

The RSUs granted to Patrick Carroll will vest in full on the company’s next quarterly vesting date. After vesting, each RSU entitles him to receive one share of Class A Common Stock, subject to applicable plan terms.

Did Patrick Carroll buy or sell any HIMS shares in this Form 4?

No open-market buy or sell occurred; the filing reports an award of 260 RSUs as compensation. The transaction is coded as a grant/award acquisition, increasing his reported derivative-based equity position.

What is Patrick Carroll’s HIMS holding reported after this RSU grant?

Following the reported transaction, Patrick Carroll holds 260 Restricted Stock Units related to Class A Common Stock. These RSUs are contingent rights that convert into shares upon vesting according to the company’s equity plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 04:22 PM Accepted by SEC EDGAR 08/14/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carroll Patrick Harrison

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

CALIFORNIA

94123

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	08/12/2026		A		260		⁽²⁾	⁽²⁾	Class A Common Stock	260	$0	260	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $7,912 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Patrick Harrison Carroll	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR